EMBLEM S-ICD Subcutaneous Electrode Model 3501. Component of implantable cardioverter defibrillator (ICD)
FDA Recall Z-0879-2021 · Posted 2021-01-19
Advertisement
Recalling FirmBoston Scientific Corporation
Recall StatusTerminated
Product CodeLWS
Date Initiated2020-11-13
Date Terminated2024-07-23
Product Quantity47000 units
Reason for Recall
There is potential for fractures which results in the inability to delivery therapy.
Firm Action
Boston Scientific will communicate worldwide to physician customers via a customer letter.
The firm notified consignees on December 2, 2020 via customer letter notifications (Dear Healthcare Professional, Dear Healthcare Administrator, and Dear Patient) .
The customers notified will be as follows:
" EMBLEM Electrode Model 3501 implanting physicians/centers and/or following
physicians/centers of record for the advisory population. Physicians associated with an advisory device will receive a list of affected model/serials for patients which they have implanted and/or followed or sent to their center.
" Centers/facilities with EMBLEM Subcutaneous Electrode Model 3501 inventory in stock.
Boston Scientific will deliver the notification by hand or email via our sales representatives or deliver the letter via Federal Express, Courier, or email.
Boston Scientific will reconcile that 100% of the identified customers /customer
representatives signed for the letter, or the letter has been confirmed to be delivered. Boston Scientific will post the product advisory letter on our website, within the Product Performance Resource Center located @ www.bostonscientific.com/en-US/pprc/productadvisories.html
Root Cause
Device Design
Distribution Pattern
Worldwide distribution including US and US territories, Canada, Latin America, Europe, Middle East, Africa, and Asia-Pacific region
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.
Advertisement